KLK3 and posterior cortical atrophy: 10,089 patients in the NCDB diagnosed from 2010 to 2012 with Gleason 3+4 disease, prostate-specific antigen < 10 mg/mL, and cT1c-2a PCa with < 50% positive biopsy cores